OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis
NCT00449722
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
380
Enrollment
INDUSTRY
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
mesalazine
Sponsor
Dr. Falk Pharma GmbH